XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 99 filers reported holding XERIS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,353,000 | -8.3% | 300,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,476,000 | -17.0% | 300,000 | 0.0% | 0.00% | -25.0% |
| Q3 2020 | $1,779,000 | +122.9% | 300,000 | 0.0% | 0.00% | +100.0% |
| Q2 2020 | $798,000 | +36.4% | 300,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $585,000 | -72.3% | 300,000 | 0.0% | 0.00% | -60.0% |
| Q4 2019 | $2,115,000 | -28.3% | 300,000 | 0.0% | 0.01% | -28.6% |
| Q3 2019 | $2,949,000 | -14.1% | 300,000 | 0.0% | 0.01% | -12.5% |
| Q2 2019 | $3,432,000 | +13.9% | 300,000 | 0.0% | 0.01% | +14.3% |
| Q1 2019 | $3,012,000 | -40.9% | 300,000 | 0.0% | 0.01% | -50.0% |
| Q4 2018 | $5,100,000 | -3.3% | 300,000 | 0.0% | 0.01% | +16.7% |
| Q3 2018 | $5,274,000 | -7.4% | 300,000 | 0.0% | 0.01% | -29.4% |
| Q2 2018 | $5,694,000 | – | 300,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,000,641 | $29,496,000 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,308,666 | $22,694,000 | 0.92% |
| ArrowMark Colorado Holdings LLC | 1,656,422 | $16,283,000 | 0.16% |
| IHT Wealth Management, LLC | 57,028 | $561,000 | 0.08% |
| MOORE CAPITAL MANAGEMENT, LP | 50,000 | $492,000 | 0.02% |
| Engineers Gate Manager LP | 20,264 | $199,000 | 0.01% |
| FEDERATED HERMES, INC. | 300,000 | $2,949,000 | 0.01% |
| FMR LLC | 4,048,102 | $39,793,000 | 0.01% |
| Invesco Ltd. | 1,000,000 | $9,830,000 | 0.00% |
| MetLife Investment Management, LLC | 14,041 | $138,023 | 0.00% |